Eczemas

Current Problems in Dermatology

Volumn 10, Issue 2, 1998, Pages 41-90

  Feingold, Sheryl ^a,b,j,l,m   Huang, Carol ^a,b   Kristal, Leonard ^a,b,g,h,i   Kalish, Richard ^a,b,h,j,k   Clark, Richard A F ^a,b,c,d,e,f  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d Strong Memorial Hospital

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^h Children's Hospital of Philadelphia ^*

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^j SUNY DOWNSTATE MEDICAL CENTER   (United States)

^k UNIVERSITY OF MINNESOTA   (United States)

^l CITY UNIVERSITY OF NEW YORK   (United States)

^m BELLEVUE HOSPITAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIPRURITIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GAMMA INTERFERON; TAR; THYMOPENTIN;

ATOPIC DERMATITIS; BACTERIAL INFECTION; CONTACT DERMATITIS; DELAYED HYPERSENSITIVITY; DIFFERENTIAL DIAGNOSIS; ECZEMA; ENVIRONMENTAL FACTOR; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNOREGULATION; MYCOSIS; PITYROSPORUM OVALE; REVIEW; SKIN MANIFESTATION; SKIN PIGMENTATION; TOPICAL DRUG ADMINISTRATION; VIRUS INFECTION; XEROSIS;

EID: 0031972023     PISSN: 10400486     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-0486(98)90008-4     Document Type: Review

References (324)

1. Coca AF, Cooke RA. On the classification of the phenomena of hypersensitiveness. J Immunol 1923;8:163-82.
2. Wise F, Sulzberger MB. Editorial comment. In: Wise F, Sulzberger MB, editors. Year book of dermatology and syphilology. Chicago: Year Book; 1933. p. 38.
3. Besnier E. Premiere note et observations preliminares pour servir d'introduction a líetude des pruripos diatrhesiques. Ann Dermatol Syphylol 1892;23:634-7.
4. Taylor B, Wadsworth J, Wadsworth M, Peckham C. Changes in the reported prevalence of childhood eczema since the 1938-45 war. Lancet 1984;2:1255-7.
5. Larsen FS, Holm NV, Henningsen K. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1986;15:487-94.
6. Williams HC. Is the prevalence of atopic dermatitis increasing? Clin Exp Dermatol 1992;17:385-91.
7. Service WC. The incidence of major allergic diseases in Colorado Springs. JAMA 1939;112:2034-7.
8. Eriksson N, Lihr Z. The incidence of allergic diseases in childhood. Acta Allergol 1955;8:289-313.
9. Walker RB, Warin RP. The incidence of eczema in early childhood. Br J Dermatol 1956;68:182-3.
10. Larsen FS, Hanifin JM. Secular change in the occurrence of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992; 176:7-12.
11. Larsen FS. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993;28:719-23.
12. Rajka G. Essential aspects of atopic dermatitis. Berlin: Springer-Verlag; 1989.
13. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994;30:35-9.
14. Dotterud LK, Kvammen B, Bolle R, Falk ES. A survey of atopic diseases among school children in Sor-Varanger community. Acta Derm Venereol 1994;74:124-8.
15. Dotterud LK, Kvammen B, Lund E, Falk ES. Prevalence and some clinical aspects of atopic dermatitis in the community of Sor-Varanger. Acta Derm Venereol 1995;75:50-3.
16. Williams HC. On the definition and epidemiology of atopic dermatitis. Dermatol Clin 1995;13:649-57.
17. Williams HC, Strachan DP, Hay RJ. Childhood eczema: disease of the advantaged. BMJ 1994;308:1132-5.
18. Diepgen TL, Fartasch M. Recent epidemiological and genetic studies in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:13-8.
19. Cookson WOCM, Sharp PA, Faux JA, et al. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11 q. Lancet 1989;1:1292-5.
20. Young RP, Sharp PA, Lynch JR, et al. Confirmation of genetic linkage between atopic IgE responses and chromosome 11q13. J Med Genet 1992;29:236-8.
21. Coleman R, Trembath RC, Harper JI. Chromosome 11q1 3 and atopy underlying atopic eczema. Lancet 1993;341(8853):1121-2.
22. Sanford AJ, Shirakawa T, Moffat MF, et al. Localisation of atopy and B subunit of high-affinity IgE-receptor (FceRI) on chromosome 11q. Lancet 1993;341:332-4.
23. Cookson W. Atopy: a complex genetic disease. Ann Med 1994;26:351-3.
24. Vickers CFH. The natural history of atopic eczema. Acta Derm Venereol Suppl (Stockh) 1980;92:113-5.
25. Burrows D, Penman RWB. Prognosis of the eczema-asthma syndrome. Br J Med 1960;2:825-8.
26. Roth HL, Kierland RR. The natural history of atopic dermatitis. Arch Dermatol 1964;89:209-14.
27. Rystedt I. Prognostic factors in atopic dermatitis. Acta Derm Venereol 1985;65:206-13.
28. Lammintausta K, Kalimo K, Raitala R, Forsten Y. Prognosis of atopic dermatitis: a prospective study in early adulthood. Int J Dermatol 1991;30:563-8.
29. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980;92:44-7.
30. Svensson A, Edman B, Moller H. A diagnostic tool for atopic dermatitis based on clinical criteria. Acta Derm Venereol Suppl (Stockh) 1985;114:33-40.
31. Diepgen TL, Fartasch M, Hornstein OP. Evaluation and relevance of atopic basic and minor features in patients with atopic dermatitis and in the general population. Acta Derm Venereol Suppl (Stockh) 1989;144:50-4.
32. Williams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994;131:383-96.
33. Williams HC, Burney PG, Strachan D, Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol 1994;131:397-405.
34. Williams HC, Burney PG, Pembroke AC, Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994; 131:406-16.
35. Tada J, Toi Y, Akiyama H, Arata J. Infra-auricular fissures in atopic dermatitis. Acta Derm Venereol 1994;74:129-31.
36. Hanifin JM. Atopic dermatitis in infants and children. Pediatr Clin North Am 1991;38:763-89.
37. Aoki T, Fukuzumi T, Adachi J, Endo K, Kojima M. Re-evaluation of skin lesion distribution in atopic dermatitis: analysis of cases O to 9 years of age. Acta Derm Venereol Suppl (Stockh) 1992;176:19-23.
38. Rystedt I. Factors influencing the occurrence of hand eczema in adults with a history of atopic dermatitis in childhood. Contact Dermatitis 1985;12:185-91.
39. Wahlgren CF. Pathophysiology of itching in urticaria and atopic dermatitis. Allergy 1992;47(2 Pt 1):65-75.
40. Wolf R, Sandbank M, Krakowski A. Extensive pityriasis alba and atopic dermatitis [letter]. Br J Dermatol 1985;112: 247.
41. Colver GB, Mortimer PS, Millard PR, Dawber RP, Ryan TJ. The 'dirty neck': a reticulate pigmentation in atopics. Clin Exp Dermatol 1987;12:1-4.
42. Linde YW. Dry skin in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;177:9-13.
43. Uehara M, Miyauchi H. The morphologic characteristics of dry skin in atopic dermatitis. Arch Dermatol 1984;120:1186-90.
44. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991;96:523-6.
45. Rabinowitz LG, Esterly NB. Atopic dermatitis and ichthyosis vulgaris. Pediatr Rev 1994;15:220-6.
46. Wells RS, Kerr CB. Clinical features of autosomal dominant and sex-linked ichthyosis in an English population. BMJ 1966;1:947.
47. Mevorah B, Marazzi A, Frenk E. The prevalence of accentuated palmoplantar markings and keratosis pilaris in atopic dermatitis, autosomal dominant ichthyosis and control dermatological patients. Br J Dermatol 1985;112:679-85.
48. Hoyer H, Agdal N, Munkvad M. Palmar hyperlinearity in atopic dermatitis. Acta Derm Venereol 1982;62:346-8.
49. Uehara M, Hayashi S. Hyperlinear palms: association with ichthyosis and atopic dermatitis. Arch Dermatol 1981;117: 490-1.
50. Garrity JA, Liesegang TJ. Ocular complications of atopic dermatitis. Can J Ophthalmol 1984;19:21-4.
51. Rich LF, Hanifin JM. Ocular complications of atopic dermatitis and other eczemas. Int Ophthalmol Clin 1985;25:61-76.
52. Meenan FOC. The significance of Morgan's fold in children with atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980;92:42.
53. Przybilla B, Ring J, Enders F, Winkelmann H. Stigmata of atopic constitution in patients with atopic eczema or atopic respiratory disease. Acta Derm Venereol 1991;71:407-10.
54. Mevorah B, Frenk E, Wietlisbach V, Carrel CF. Minor clinical features of atopic dermatitis: evaluation of their diagnostic significance. Dermatologica 1988;177:360-4.
55. Uehara M. Infraorbital fold in atopic dermatitis. Arch Dermatol 1981;117:627-9.
56. Brunsting LA, Reed WB, Bair HL. Occurrence of cataracts and keratoconus with atopic dermatitis. Arch Dermatol Syphilol 1955;72:237-41.
57. Foster CS, Calogne M. Atopic keratoconjunctivitis. Ophthalmology 1990;97:992-1000.
58. Oshinskie L, Haine C. Atopic dermatitis and its ophthalmic complications. J Am Optom Assoc 1982;53:889-94.
59. Katavisto M. Prurigo diathesique Besnier and cataract. Acta Ophthalmol 1949;27:581.
60. Christensen JD. Frequency of cataract in atopic dermatitis. Acta Derm Venereol 1981;61:76-7.
61. Uehara M, Amemiya T, Arai M. Atopic cataracts in a Japanese population: with special reference to factors possibly relevant to cataract formation. Dermatologica 1985;170: 180-4.
62. Amemiya T, Matsuda H, Uehara M. Ocular findings in atopic dermatitis with special reference to the clinical features of atopic cataract. Ophthalmologica 1980;180:129-32.
63. Castrow FD. Atopic cataracts versus steroid cataracts. J Am Acad Dermatol 1981;5:64-6.
64. Oka C, Ideta H, Nagasaki H, Watanabe K, Shinagawa K. Retinal detachment with atopic dermatitis similar to traumatic retinal detachment. Ophthalmology 1994;101:1050-4.
65. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974;90:525-30.
66. Klein PA, Greene WH, Fuhrer J, Clark RAF. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in out-patients with psoriasis, atopic dermatitis, or HIV infection. Arch Dermatol. In press.
67. Svejgaard E. The role of microorganisms in atopic dermatitis. Semin Dermatol 1990;9:255-61.
68. Williams H, Pottier A, Strachan D. Are viral warts seen more commonly in children with eczema? [see comments]. Arch Dermatol 1993;129:717-20.
69. Hanifin JM, Ray LF, Lobitz WCJ. Immunologic reactivity in dermatophytosis. Br J Dermatol 1974;90:1-8.
70. Jones HE. The atopic-dermatophytosis syndrome. Acta Derm Venereol 1980;92:81-5.
71. Svejgaard E, Faergeman J, Jemec G, Kieffer M, Ottevanger V. Recent investigations on the relationship between fungal skin diseases and atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989;144:140-2.
72. Clemmensen OJ, Hjorth N. Treatment of dermatitis of the head and neck with ketoconazole in patients with type 1 sensitivity to Pityrosporon orbiculare. Semin Dermatol 1983; 2:26-9.
73. Abrahamov A, Schifmann R, Goldstein R, Tal Y, Freier S. Growth failure due to protein loss in dermatitis. Eur J Pediatr 1986;145:223-6.
74. Freedberg IM, Baden HP. The metabolic response to exfoliation. J Invest Dermatol 1962;38:277-85.
75. Yoshiike T, Aikawa Y, Sindhvananda J, Suto H, Nishimura K, Kawamoto T, et al. Skin barrier defect in atopic dermatitis: increased permeability of the stratum corneum using dimethyl sulfoxide and theophylline. J Dermatol Sci 1993;5: 92-6.
76. Lammintausta K, Kalimo K. Does a patient's occupation influence the course of atopic dermatitis? Acta Derm Venereol 1993;73:119-22.
77. Adinoff AD, Tellez P, Clark RA. Atopic dermatitis and aeroallergen contact sensitivity. J Allergy Clin Immunol 1988;81:736-42.
78. Morren MA, Przybilla B, Bamelis M, Heykants B, Reynaers A, Degreef H. Atopic dermatitis: triggering factors. J Am Acad Dermatol 1994;31(3 Pt 1):467-73.
79. Kay AB. Allergen injection immunotherapy (hyposensitization) on trial. Clin Exp Allergy 1989;119:591-6.
80. Norman PS. Immunotherapy. Prog Allergy 1982;32:318-46.
81. Glover MT, Atherton DJ. A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exp Allergy 1992;22: 440-6.
82. Sampson HA, Jolie PL. Increased plasma histamine concentrations after food challenges in children with atopic dermatitis. N Engl J Med 1984;311:372-6.
83. Clark RAF, Adinoff AD. Aeroallergen contact can exacerbate atopic dermatitis: patch tests as a diagnostic tool. J Am Acad Dermatol 1989;21(4 Pt 2):863-9.
84. Clark RAF, Adinoff AD. The relationship between positive aeroallergen patch test reactions and aeroallergen exacerbations of atopic dermatitis. Clin Immunol Immunopathol 1989;53(2 Pt 2):S132-40.
85. Cronin E, McFadden JP. Patients with atopic eczema do become sensitized to contact allergens. Contact Dermatitis 1993;28:225-8.
86. Rothe MJ, Grant-Kels JM. Atopic dermatitis: an update. J Am Acad Dermatol 1996;35:1-13.
87. Gloor M, Peters G, Stoika D. On the resident aerobic bacterial skin flora in unaffected skin of patients with atopic dermatitis and in healthy controls. Dermatologica 1982;164: 258-65.
88. Roth RR, James WD. Microbiology of the skin: resident flora, ecology, infection. J Am Acad Dermatol 1989;20:367-90.
89. Halbert AR, Weston WL, Morelli JG. Atopic dermatitis: Is it an allergic disease? [see comments]. J Am Acad Dermatol 1995;33:1008-18.
90. Kieffer M, Bergbrant IM, Faergemann J, Jemec GB, Ottevanger V, Stahl Skov P, et al. Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrheic dermatitis. J Am Acad Dermatol 1990;22(5 Pt 1):739-42.
91. Broberg A, Faergemann J, Johansson S, Johansson SG, Strannegaard IL, Svejgaard E. Pityrosporum ovale and atopic dermatitis in children and young adults. Acta Derm Venereol 1992;72:187-92.
92. Waersted A, Hjorth N. Pityrosporum orbiculare: a pathogenic factor in atopic dermatitis of the face, scalp and neck? Acta Derm Venereol Suppl (Stockh) 1985;114:146-8.
93. Garrie EV, Garrie SA, Mok T. Anxiety and atopic dermatitis. J Consult Clin Psychol 1974;42:742.
94. Faulstich ME, Williamson DA, Duchmann EG, Conerly SL, Brantley PJ. Psychophysiological analysis of atopic dermatitis. J Psychosom Res 1985;29:415-7.
95. Koblenzer CS. Psychotherapy for intractable inflammatory dermatoses. J Am Acad Dermatol 1995;32:609-12.
96. Yamamoto K, Korstanje M. Eczema in childhood. In: Marks R, editor. Eczema. London: Martin Dunitz; 1992. p. 239-53.
97. Cole WC, Roth HL, Sachs LB. Group psychotherapy as an aid in the medical treatment of eczema. J Am Acad Dermatol 1988;18(2 Pt 1):286-91.
98. Pincelli C, Fantini F, Massimi P, Girolomoni G, Seidenari S, Giannetti A. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 1990;122:745-50.
99. Ostlere LS, Cowen T, Rustin MH. Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol 1995; 20:462-7.
100. Tobin D, Nabarro G, Baart de la Faille H, van Vloten WA, van der Putte SC, Schuurman HJ. Increased number of immunoreactive nerve fibers in atopic dermatitis. J Allergy Clin Immunol 1992;90(4 Pt 1):613-22.
101. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy [see comments]. J Invest Dermatol 1994;102: 128-37.
102. Leung DY. Atopic dermatitis: immunobiology and treatment with immune modulators. Clin Exp Immunol 1997;1: 25-30.
103. Lever WF, Lever GS. Histopathology of the skin. Philadelphia: Lippincott; 1990. p. 104-8.
104. Mihm MC, Soter NA, Dvorak HF. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976;67:305-12.
105. Gurevitch AW, Heiner DC, Reisner R. IgE in atopic dermatitis and other common dermatoses. Arch Dermatol 1973;107:712.
106. Stone SP, Muller SA, Gleich GJ. IgE levels in atopic dermatitis. Arch Dermatol 1973;108:806-11.
107. Jones HE, Inouye JC, McGerity JL, Lewis CW. Atopic disease and serum immunoglobulin E. Br J Dermatol 1975;92:17-25.
108. Ohman S, Johansson SGO. Immunoglobulins in atopic dermatitis with special reference to IgE. Acta Derm Venereol 1974;54:193-202.
109. Leung DYM, Geha RS, Schneeberger EE, et al. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 1983;71:47-56.
110. Lever R, Turbitt M, Sanderson A, MacKie R. Immunophenotyping of the cutaneous infiltrate and of the mononuclear cells in the peripheral blood in patients with atopic dermatitis. J Invest Dermatol 1987;89:4-7.
111. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
112. Rotteveel FTM, Kokkelnik I, van Lien RAW, Kuenen B, et al. Clonal analysis of functionally distinct human CD4+ T cell subsets. J Exp Med 1988;168:1659-73.
113. Kapsenberg ML, Wierenga EA, Bos JD, Jansen HM. Functional subsets of allergenreactive human CD4+ T cells. Immunol Today 1991;12:392-5.
114. Pene J, Rousset F, Briere F, Christien I, Paliard X, et al. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-γ. J Immunol 1988;141:1218-24.
115. Mosmann TR, Moore KW. The role of IL-10 in crossregulation of Th1 and Th2 responses. Immunol Today 1991;12:49-53.
116. Wierenga EA, Snoek M, deGroot C, et al. Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 1990;144:4651-6.
117. van der Heijden FL, Wierenga EA, Bos JD, Kapsenberg ML. High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991;97:389-94.
118. Holden CA, Chan SC, Hanifin JM. Monocyte localization of elevated cAMP phosphodiesterase activity in atopic dermatitis. J Invest Dermatol 1986;87:372-6.
119. Hanifin JM. Phosphodiesterase and immune dysfunction in atopic dermatitis. J Dermatol Sci 1990;1:1-6.
120. Heskel NS, Chan SC, Thiel ML, Stevens SR, Casperson LS, Hanifin JM. Elevated umbilical cord blood leukocyte cyclic adenosine monophosphate-phosphodiesterase activity in children with atopic parents. J Am Acad Dermatol 1984;11: 422-6.
121. Grewe SR, Chan SC, Hanifin JM. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness. J Allergy Clin Immunol 1982;70:452-7.
122. Kim JW, Chan SC, Handerson W, Hanifin JM. Disordered prostaglandin E2 control of cytokine production in atopic dermatitis. J Invest Dermatol 1992;98:610.
123. Phipps RP, Stein SH, Roper RL. A new view of prostaglandin regulation of the immune response. Immunol Today 1991;12:349-52.
124. Chan SC, Audrea C, Rocklin R, et al. Cyclic nucleotide regulation of T cell cytokine production and feedback control in atopic dermatitis [abstract]. Clin Res 1993;41:5A.
125. Uehara M, Izukura R, Sawai T. Blood eosinophilia in atopic dermatitis. Clin Exp Dermatol 1990;15:264-6.
126. Kapp A, Czech W, Krutmann J, Schopf E. Eosinophil cationic protein in sera of patients With atopic dermatitis. J Am Acad Dermatol 1992;24:555-8.
127. Czech W, Krutmann J, Schopf E, Kapp A. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 1992;126:351-5.
128. Leiferman KM, Ackerman SJ, Sampson HA, Haugen HS, Venencie PY, Gleich GJ. Dermal deposition of eosinophilgranule major basic protein in atopic dermatitis: comparison with onchocerciasis. N Engl J Med 1985;313:282-5.
129. Rubin LA, Kurman CC, Fritz ME, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985;137:3172-7.
130. Colver GB, Symons JA, Duff GW. Soluble interleukin 2 receptor in atopic eczema. BMJ 1989;298(6685):1426-8.
131. Uno H, Hanifin JM. Langerhans cells in acute and chronic epidermal lesions of atopic dermatitis, observed by L-dopa histofluorescence, glycol methacrylate thin secretion, and electron microscopy. J Invest Dermatol 1980;75:52-60.
132. Rocha C, de Maubeuge J, Sarfati M, Song M, Delespesse G. Characterization of cellular infiltrates in skin lesions of atopic eczema by means of monoclonal antibodies. Dermatologica 1984;169:330-8.
133. Zachary CB, Allen MH, MacDonald DM. In situ quantification of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic eczema. Br J Dermatol 1985;112:149-56.
134. Bieber T, de la Salle H, Wollenberg A, et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (FC epsilon R1). J Exp Med 1992;175: 1285-90.
135. Wang B, Rieger A, Kilgus O, et al. Epidermal Langerhans cells from normal human skin bind monomeric IgE via FceR1. J Exp Med 1992;175:1353-65.
136. Mudde GC, Van Reijsen FC, Boland GJ, de Gast GC, Bruijnzeel PL, Bruijnzeel-Koomen CA. Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE. Immunology 1990; 69:335-41.
137. Taylor RS, Baadsgaard O, Hammerberg C, Cooper KD. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis. J Immunol 1991;147:3794-802.
138. Bradding P, Feather IH, Howarth PH, et al. Interleukin 4 is localized and released by human mast cells. J Exp Med 1992;176:1381-6.
139. Jones HE, Lewis C, McMarlin SL. Allergic contact sensitivity in atopic dermatitis. Arch Dermatol 1973;107:217-22.
140. Uehara M, Sawai T. A longitudinal study of contact sensitivity in patients with atopic dermatitis. Arch Dermatol 1989;125:366-8.
141. Neuber K, Konig W. Effects of Staphylococcus aureus cell wall products (teichoic acid, peptidoglycan) and enterotoxin B on immunoglobulin (IgE, IgA, IgG) synthesis and CD23 expression in patients with atopic dermatitis. Immunology 1992;75:23-8.
142. Leung DY, Harbeck R, Bina P, Reiser RF, Yang E, Norris DA, et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: evidence for a new group of allergens. J Clin Invest 1993;92: 1374-80.
143. McFadden JP, Noble WC, Camp RD. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1003;128:631-2.
144. Sampson HA, Albergo R. Comparison of results of skin tests, RAST, and double-blind, placebo-controlled food challenges in children with atopic dermatitis. J Allergy Clin Immunol 1984;74:26-33.
145. May CD. Objective and clinical laboratory studies of immediate hypersensitivity reactions to foods in asthmatic children. J Allergy Clin Immunol 1976;58:500-.
146. Bock SA, Lee WY, Remigio LK, May CD. Studies of hypersensitivity reactions to food in infants and children. J Allergy Clin Immunol 1978;62:327-.
147. Hanifin JM. Significance of food hypersensitivity in children with atopic dermatitis. Pediatr Dermatol 1986;3:161-74.
148. Sampson HA, McCaskill CC. Food hypersensitivity and atopic dermatitis: evaluation of 113 patients. J Pediatr 1985; 107:669-75.
149. Sampson HA. Role of immediate food hypersensitivity in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1983;71:473-80.
150. Guillet G, Guillet MH. Natural history of sensitizations in atopic dermatitis: a 3-year follow-up in 250 children: food allergy and high risk of respiratory symptoms. Arch Dermatol 1992;128:187-92.
151. Bock SA. The natural history of food sensitivity. J Allergy Clin Immunol 1982;69:173-7.
152. Burks AW, Mallory SB, Williams LW, Shirrell MA. Atopic dermatitis: clinical relevance of food hypersensitivity reactions. J Pediatr 1988;113:447-51.
153. Sampson HA. The immunopathogenic role of food hypersensitivity in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:34-7.
154. Sampson HA. Food sensitivity and the pathogenesis of atopic dermatitis. J R Soc Med 1997;30:2-8.
155. Sampson HA, Scanlon SM. Natural history of food hypersensitivity in children with atopic dermatitis. J Pediatr 1989; 115:23-7.
156. Sampson HA, Broadbent KR, Bernhisel-Broadbent J. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity [see comments]. N Engl J Med 1989; 321:228-32.
157. Halpern SR, Sellars WA, Johnson RB, et al. Development of childhood allergy in infants fed breast, soy, or cow's milk. J Allergy Clin Immunol 1973;51:139.
158. Kjellman NIM, Johansson SG. Soy versus cow's milk in infants with a biparental history of atopic disease: development of atopic disease and immunoglobulins from birth to 4 years of age. Clin Allergy 1979;9:347-58.
159. Gustafson D, Lowhagen T, Andersson K. Risk of developing atopic disease after early feeding with cow's milk based formula. Arch Dis Child 1992;67:1008-10.
160. Zeiger RS, Heller S, Mellon MH, Halsey JF, Hamburger RN, Sampson HA. Genetic and environmental factors affecting the development of atopy through age 4 in children of atopic parents: a prospective randomized study of food allergen avoidance. Pediatr Allergy Immunol 1992;3:110-27.
161. Oranje AP, Aarsen RS, Mulder PG, van Toorenenbergen AW, Liefaard G, Dieges PH. Food immediate-contact hypersensitivity (FICH) and elimination diet in young children with atopic dermatitis: preliminary results in 107 children. Acta Derm Venereol Suppl (Stockh) 1992;176: 41-4.
162. Peck SM, Salomon G. Eczema of infancy and childhood: contacts as etiologic agents, with particular reference to feathers. Am J Dis Child 1933;46:1308.
163. Feinberg SM. Seasonal atopic dermatitis: the role of inhaled atopens. Arch Derm Syph 1939;40:200.
164. Tuft L. Importance of inhalant allergens in atopic dermatitis. J Invest Dermatol 1949;12:211-9.
165. Tuft L, Heck VM. Studies in atopic dermatitis. IV. Importance of seasonal inhalant allergens, especially ragweed. J Allergy 1952;23:528-40.
166. Reitamo S, Visa K, Kahonen K, Kayhko K, Stubb S, Salo OP. Eczematous reactions in atopic patients caused by epicutaneous testing with inhalant allergens. Br J Dermatol 1986;114:303-9.
167. Norris PG, Schofield O, Camp RD. A study of the role of house dust mite in atopic dermatitis. Br J Dermatol 1988; 118:435-40.
168. Mitchell EB, Crow J, Chapman MD, Jouhal SS, Pope FM, Platts-Mills TA. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet 1982;1(8264):127-30.
169. Beck HI, Korsgaard J. Atopic dermatitis and house dust mites. Br J Dermatol 1989;120:245-51.
170. Colloff MJ. Exposure to house dust mites in homes of people with atopic dermatitis. Br J Dermatol 1992;127:322-7.
171. Sanda T, Yasue T, Oohashi M, Yasue A. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol 1992;89:653-7.
172. Tupker RA, De Monchy JG, Coenraads PJ, Homan A, van der Meer JB. Induction of atopic dermatitis by inhalation of house dust mite. J Allergy Clin Immunol 1996;97:1064-70.
173. Tan BB, Weald D, Strickland I, Friedmann PS. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996;347(8993):15-8.
174. Leroy BP, Boden G, Lachapelle JM, Jacquemin MG, Saint-Remy JM. A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study. J Am Acad Dermatol 1993;28(2 Pt 1):232-9.
175. Ring J. Successful hyposensitization treatment in atopic eczema: results of a trial in monozygotic twins. Br J Dermatol 1982;107:597-602.
176. Zachariae H, Cramers M, Herlin T, Jensen J, Kragballe K, Ternowitz T, et al. Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1985;114:48-54.
177. Saurat JH. Specific hyposensitization for atopic dermatitis: a new era? [editorial; comment]. Dermatologica 1991;182:71-2.
178. Friedman SJ, Schroeter AL, Homburger HA. IgE antibodies to Staphylococcus oureus: prevalence in patients with atopic dermatitis. Arch Dermatol 1985;121:869-72.
179. Motala C, Potter PC, Weinberg EG, Malherbe D, Hughes J. Anti-Staphylococcus aureus-specific IgE in atopic dermatitis. J Allergy Clin Immunol 1986;78(4 Pt 1):583-9.
180. Michie CA, Davis T. Atopic dermatitis and staphylococcal superantigens [letter]. Lancet 1996;347(8997):324.
181. Strange P, Skov L, Lisby S, Nielsen PL, Baadsgaard O. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996; 132:27-33.
182. Kroger S, Neuber K, Gruseck E, Ring J, Abeck D. Pityrosporum ovale extracts increase interleukin-4, interleukin-10 and IgE synthesis in patients with atopic eczema. Acta Derm Venereol 1995;75:357-60.
183. Lindgren L, Wahlgren CF, Johansson SG, Wiklund I, Nordvall SL. Occurrence and clinical features of sensitization to Pityrosporum orbiculare and other allergens in children with atopic dermatitis. Acta Derm Venereol 1995; 75:300-4.
184. Tengvall Linder M, Johansson C, Zargari A, Bengtsson A, van der Ploeg I, Jones I, et al. Detection of Pityrosporum orbiculare reactive T cells from skin and blood in atopic dermatitis and characterization of their cytokine profiles. Clin Exp Allergy 1996;26:1286-97.
185. Lintu P, Savolainen J, Kalimo K. IgE antibodies to protein and mannan antigens of Pityrosporum ovale in atopic dermatitis patients. Clin Exp Allergy 1997;27:87-95.
186. Queille-Roussel C, Raynaud F, Saurat JH. A prospective computerized study of 500 cases of atopic dermatitis in childhood. I. Initial analysis of 250 parameters. Acta Derm Venereol Suppl (Stockh) 1985;114:87-92.
187. Martin AJ, Landau LI, Phelan PD. Predicting the course of asthma in children. Aust Pediatr J 1982;18:84-7.
188. Fergusson DM, Horwood LJ, Shannon FT. Parental asthma, parental eczema, and asthma and eczema in early childhood. J Chronic Dis 1983;36:517-24.
189. Salob SP, Atherton DJ. Prevalence of respiratory symptoms in children with atopic dermatitis attending pediatric dermatology clinics. Pediatrics 1993;91:8-12.
190. Salob SP, Laverty A, Atherton DJ. Bronchial hyperresponsiveness in children with atopic dermatitis. Pediatrics 1993; 91:13-6.
191. Epstein S, Moharjerin A. Incidence of contact sensitivity in atopic dermatitis. Arch Dermatol 1964;90:284-7.
192. Schopf E, Baumgartner A. Patch testing in atopic dermatitis. J Am Acad Dermatol 1989;21(4 Pt 2):860-2.
193. Cronin E, Bandemann HJ, Calnan D, et al. Contact dermatitis in the atopic. Acta Derm Venereol 1970;50:183-7.
194. de Groot AC. The frequency of contact allergy in atopic patients with dermatitis. Contact Dermatitis 1990;22:273-7.
195. Zeiger RS, Heller S. The development and prediction of atopy in high-risk children: follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol 1995;95:1179-90.
196. Ruiz RGG, Richards D, Kemeny DM, et al. Neonatal IgE: a poor screen for atopic disease. Clin Exp Allergy 1992;21: 467-72.
197. Tang ML, Varigos G, Kemp AS. Reduced interferon-γ (IFN-γ) secretion with increased IFN-γ mRNA expression in atopic dermatitis: evidence for a post-transcriptional defect. Clin Exp Immunol 1994;97:483-90.
198. Borres MP, Odelram H, Irander K, Kjellman NI, Bjorksten B. Peripheral blood eosinophilia in infants at 3 months of age is associated with subsequent development of atopic disease in early childhood. J Allergy Clin Immunol 1995;95:694-8.
199. Yates VM, Kerr RE, Frier K, Cobb SJ, MacKie RM. Early diagnosis of infantile seborrhoeic dermatitis and atopic dermatitis: total and specific IgE levels. Br J Dermatol 1983; 108:639-45.
200. Sigurs N, Hattevig G, Kjellman B, et al. Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years. J Allergy Clin Immunol 1994;94:757-63.
201. Galli E, Picardo M, Chini L, et al. Analysis of polyunsaturated fatty acids in newborn sera: a screening tool for atopic disease? Br J Dermatol 1994;130:752-6.
202. Yates VM, Kerr RE, MacKie RM. Early diagnosis of infantile seborrhoeic dermatitis and atopic dermatitis: clinical features. Br J Dermatol 1983;108:633-8.
203. Lever R, Forsyth A. Allergic contact dermatitis in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:95-8.
204. Scholtz JR. Management of atopic dermatitis. Calif Med 1965;102:210.
205. Frosch PJ, Schwanitz HJ, Macher E. A double blind trial of H1 and H2 receptor antagonists in the treatment of atopic dermatitis. Arch Dermatol Res 1984;276:36-40.
206. Savin JA, Dow R, Harlow BJ, Massey H, Yee KF. The effect of a new non-sedative H1-receptor antagonist (LN2974) on the itching and scratching of patients with atopic eczema. Clin Exp Dermatol 1986;11:600-2.
207. Wahlgren CF, Hagermark O, Bergstrom R. The antipruritic effect of a sedative and a nonsedative antihistamine in atopic dermatitis. Br J Dermatol 1990;122:545-51.
208. Drake LA, Fallon JD, Sober A. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream: the Doxepin Study Group. J Am Acad Dermatol 1994;31:613-6.
209. La Rosa M, Ranno C, Musarra I, Guglielmo F, Corrias A, Bellanti JA. Double-blind study of cetirizine in atopic eczema in children. Ann Allergy 1994;73:117-22.
210. Veien NK, Kaaber K, Larsen PO, Nielsen AO, Thestrup-Pedersen K. Ranitidine treatment of hand eczema in patients with atopic dermatitis: a double-blind, placebo-controlled trial. J Am Acad Dermatol 1995;32:1056-7.
211. Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 1992;27:29-34.
212. Wolthers OD, Heuck C, Ternowitz T, Heickendorff L, Nielsen HK, Frystyk J. Insulin-like growth factor axis, bone and collagen turnover in children with atopic dermatitis treated with topical glucocorticosteroids. Dermatology 1996;192:337-42.
213. Lever R, Hadley K, Downey D, Mackic R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988;119:189-98.
214. Luber H, Amornsiripanitch S, Lucky AW. Mupirocin and the eradication of Staphylococcus aureus in atopic dermatitis. Arch Dermatol 1988;124:853-4.
215. Chen YP, Wu YC. Eczema herpeticum in three siblings: clinical features and acyclovir treatment. J Dermatol 1986; 13:334-8.
216. van der Valk PG, Snater E, Verbeek-Gijsbers W, Duller P, van de Kerkhof PC. Out-patient treatment of atopic dermatitis with crude coal tar. Dermatology 1996;193:41-4.
217. Morison WL, Parrish JA, Fitzpatrick TB. Oral psoralen photochemotherapy of atopic eczema. Br J Dermatol 1978;98: 25-30.
218. Atherton DJ, Carabott F, Glover MT, Hawk JL. The role of psoralen photochemotherapy (PUVA) in the treatment of severe atopic eczema in adolescents. Br J Dermatol 1988; 118:791-5.
219. Sheehan MP, Atherton DJ, Norris P, Hawk J. Oral psoralen photochemotherapy in severe childhood atopic eczema: an update. Br J Dermatol 1993;129:431-6.
220. Jekler J, Larko O. Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: a paired-comparison study. J Am Acad Dermatol 1990;22:49-53.
221. Krutmann J, Schopf E. High-dose-UVA1 phototherapy: a novel and highly effective approach for the treatment of acute exacerbation of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:120-2.
222. Jekler J, Larko O. UVA solarium versus UVB phototherapy of atopic dermatitis: a paired-comparison study. Br J Dermatol 1991;125:569-72.
223. Kowalzick L, Kleinheinz A, Weichenthal M, Neuber K, Kohler I, Grosch J, et al. Low dose versus medium dose UV-A1 treatment in severe atopic eczema. Acta Derm Venereol 1995;75:43-5.
224. George SA, Bilsland DJ, Johnson BE, Ferguson J. Narrowband (TL-01) UVB air-conditioned phototherapy for chronic severe adult atopic dermatitis [see comments]. Br J Dermatol 1993;128:49-56.
225. Ogawa H, Yoshiike T. Atopic dermatitis: studies of skin permeability and effectiveness of topical PUVA treatment. Pediatr Dermatol 1992;9:383-5.
226. Boguniewicz M, Jaffe HS, Izu A, Sullivan MJ, York D, Geha RS, et al. Recombinant gamma Interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med 1990;88:365-70.
227. Reinhold U, Wehrmann W, Kukel S, Kreysel HW. Recombinant interferon-γ in severe atopic dermatitis [letter]. Lancet 1990;335(8700):1282.
228. Hanifin JM, Schneider LC, Leung DY, Ellis CN, Jaffe HS, Izu AE, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993;28(2 Pt 1):189-97.
229. Nishioka K, Matsunaga T, Katayama I. γ-Interferon therapy for severe cases of atopic dermatitis of the adult type. J Dermatol 1995;22:181-5.
230. van Joost T, Stolz E, Heule F. Efficacy of low-dose cyclosporine in severe atopic skin disease [letter]. Arch Dermatol 1987;123:166-7.
231. Stephens RB, Lee ML, Cooper A. Cyclosporin treatment of atopic dermatitis: five case studies and literature review. Australas J Dermatol 1994;35:55-9.
232. Berth-Jones J, Finlay AY, Zaki I, Tan B, Goodyear H, Lewis-Jones S, et al. Cyclosporine in severe childhood atopic dermatitis: a multicenter study [see comments]. J Am Acad Dermatol 1996;34(6):1016-21.
233. Sepp N, Fritsch PO. Can cyclosporin A induce permanent remission of atopic dermatitis? Br J Dermatol 1993;128:213-6.
234. Zachariae H. Long-term use of cyclosporine in dermatology [editorial; comment]. Arch Dermatol 1996;132:692-4.
235. de Prost Y, Bodemer C, Teillac D. Randomised double-blind placebo-controlled trial of local cyclosporin in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989;144:136-8.
236. 235a. Ruzicka, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med 1997;337:816-21.
237. Aoyama H, Tabata N, Tanaka M, Uesugi Y, Tagami H. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment [letter]. Br J Dermatol 1995;133:494-6.
238. Kang K, Cooper KD, Hanifin JM. Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis. J Am Acad Dermatol 1983;8:372-7.
239. Leung DY, Hirsch RL, Schneider L, Moody C, Takaoka R, Li SH, et al. Thymopentin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol 1990;85: 927-33.
240. Stiller MJ, Shupack JL, Kenny C, Jondreau L, Cohen DE, Soter NA. A double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymopentin as an adjunctive treatment in atopic dermatitis. J Am Acad Dermatol 1994;30:597-602.
241. Harper JI, Mason UA, White TR, Staughton RC, Hobbs JR. A double-blind placebo-controlled study of thymostimulin (TP-1) for the treatment of atopic eczema. Br J Dermatol 1991;125:368-72.
242. Manku MS, Horrobin DF, Morse NL, Wright S, Burton JL. Essential fatty acids in the plasma phospholipids of patients with atopic eczema. Br J Dermatol 1984;110:643-8.
243. Urton JL. Dietary fatty acids and inflammatory skin disease. Lancet 1989;1:27-31.
244. Guenther L, Wexler D. Efamol in the treatment of atopic dermatitis [letter]. J Am Acad Dermatol 1987;17(5 Pt 1):860.
245. Rasmussen JE. Advances in nondietary management of children with atopic dermatitis. Pediatr Dermatol 1989;6:210-5.
246. Wright S, Burton JL. Oral evening-primrose-seed oil improves atopic eczema. Lancet 1982;2(8308):1120-2.
247. Fiocchi A, Sala M, Signoroni P, Banderali G, Agostoni C, Riva E. The efficacy and safety of gamma-linolenic acid in the treatment of infantile atopic dermatitis. J Int Med Res 1994;22:24-32.
248. Soyland E, Funk J, Rajka G, Sandberg M, Thune P, Rustad L, et al. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis: a double-blind, multicentre study. Br J Dermatol 1994;130:757-64.
249. Mabin DC, Sykes AE, David TJ. Controlled trial of a few foods diet in severe atopic dermatitis. Arch Dis Child 1995;73:202-7.
250. Stewart AC, Thomas SE. Hypnotherapy as a treatment for atopic dermatitis in adults and children. Br J Dermatol 1995; 132:778-83.
251. Leroy BP, Jacquemin MG, Lachapelle JM, Saint-Remy JM. Allergen-sensitive atopic dermatitis is improved by injections of allergen combined with F(ab′)2 fragments of specific antibodies. Br J Dermatol 1995;132:599-603.
252. Sheehan MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol 1992;126:179-84.
253. Sheehan MP, Rustin MH, Atherton DJ, Buckley C, Harris DW, Brostoff J, et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis [published erratum appears in Lancet 1992 Jul 18;340(8812):188] [see comments]. Lancet 1992;340(8810):13-7.
254. Sheehan MP, Atherton DJ. One-year follow up of children treated with Chinese medicinal herbs for atopic eczema. Br J Dermatol 1994;130:488-93.
255. Latchman Y, Bungy GA, Atherton DJ, Rustin MH, Brostoff J. Efficacy of traditional Chinese herbal therapy in vitro: a model system for atopic eczema: inhibition of CD23 expression on blood monocytes. Br J Dermatol 1995;132:592-8.
256. Xu XJ, Banerjee P, Rustin MH, Poulter LW. Modulation by Chinese herbal therapy of immune mechanisms in the skin of patients with atopic eczema. Br J Dermatol 1997;136:54-9.
257. Cooper KD, Kang K, Chan SC, Hanifin JM. Phosphodiesterase inhibition by Ro 20-1724 reduces hyper-IgE synthesis by atopic dermatitis cells in vitro. J Invest Dermatol 1985;84:477-82.
258. Prinz B, Nachbar F, Plewig G. Treatment of severe atopic dermatitis with extracorporeal photopheresis. Arch Dermatol Res 1994;287:48-52.
259. Dupuis G, Benezra C. Chemically reactive functions in haptens and in proteins. In Allergic contact dermatitis to simple chemicals: a molecular approach. City: Marcel Dekker; 1982. p. 47-84.
260. Romagnoli P, Sinigaglia F. Selective interaction of Ni with an MHC-bound peptide. EMBO J 1991;10:1303-06.
261. Hauser C, Saurat J, Schmitt A, et al. Interleukin 1 is present in normal human epidermis. J Immunol 1986;136:3317-21.
262. Kupper TS, Ballard D, Chua AO, et al. Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. J Exp Med 1986;164:2095-100.
263. Kupper TS. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol 1990;94:146S-50S.
264. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987;329:506-12.
265. Bjorkman PJ, Sapper MA, Samaroui B, Bennett WS, Strominger JL, Wiley DC. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987;329:512-8.
266. Meuer SC, Schlossman SF, Reinherz EL. Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci U S A 1982;79: 4395-9.
267. Kalish RS, Wood JA, LaPorte A. Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to human T-cells. J Clin Invest 1994;93:2039-47.
268. Kalish RS. Antigen processing: the gateway to the immune response. J Am Acad Dermatol 1995;32:640-52.
269. Kripke ML, Munn CG, Jeevan A, Tang JM, Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 1990;145:2833-8.
270. Kalish RS, Johnson KL. Enrichment and function of urushiol (poison ivy) specific T-lymphocytes in lesions of allergic contact dermatitis to urushiol. J Immunol 1990;145:3706-13.
271. Picker LJ. Regulation of tissue-selective T-lymphocyte homing receptors during the virgin to memory/effector cell transition in human secondary lymphoid tissues. Am Rev Respir Dis 1990;148:847-54.
272. Picker LJ, Martin RJ, Trumble A, Newman LS, Collins PA, Bergstresser PR, et al. Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur J Immunol 1994;24:1269-77.
273. Bos JD, de Boer OJ, Tibosch E, Das PK, Pals ST. Skin-homing T lymphocytes: detection of cutaneous lymphocyte-associated antigen (CLA) by HECA-452 in normal human skin. Arch Dermatol Res 1993;285:179-83.
274. Alon R, Rossiter H, Wang X, Springer TA, Kupper TS. Distinct cell surface ligands mediate T lymphocyte attachment and rolling on P and E selection under physiological flow. J Cell Biol 1994;127:1485-95.
275. Yago T, Tsukuda M, Yamazaki H, Nishi T, Amano T, Minami M. Analysis of an initial step of T cell adhesion to endothelial monolayers under flow conditions. J Immunol 1995;154:1216-22.
276. Jones DA, Mclntire LV, Smith CW, Picker LJ. A two-step adhesion cascade for T cell/endothelial cell interactions under flow conditions. J Clin Invest 1994;94:2443-50.
277. Das, PK, de Boer OJ, Visser A, Verhagen CE, Bos JD, Pals ST. Differential expression of ICAM- 1, E-selection and VCAM- 1 by endothelial cells in psoriasis and contact dermatitis. Acta Dermatol Venereol Suppl 1994;186:21-22.
278. Wildner O, Lipkow T, Knop J. Increased expression of ICAM-1, E-selection, and VCAM-1 by cultured human endothelial cells upon exposure to haptens. Exp Dermatol 1992;1:191-8.
279. Piguet PF, Grau GE, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med 1991;173:673-9.
280. Marks JG, DeLeo VA. Contact and occupational dermatology. St. Louis: Mosby; 1992.
281. Fisher AA. Contact dermatitis. Philadelphia: Lea & Feiger; 1986.
282. Lepoittevin JP, Drieghe J, Dooms-Goossens A. Studies in patients with corticosteroid contact allergy. Arch Dermatol 1995;131:31-7.
283. Rietschel RL. Patch testing for corticosteroid allergy in the United States. Arch Dermatol 1995;131:91-2.
284. Knudsen BB, Larsen E, Egsgaard H, Menne T. Release of thiurams and carbamates from rubber gloves. Contact Dermatitis 1993;28:63-9.
285. Charous BL, Hamilton RG, Yunginger JW. Occupational latex exposure: characteristics of contact and systemic reactions in 47 workers. J Allergy Clin Immunol 1994;94:12-8.
286. Wrangsjo K, Osterman K, van Hage-Hamsten M. Glove-related skin symptoms among operating theatre and dental care unit personnel (II). Clinical examination, tests and laboratory findings indicating latex allergy. Contact Dermatitis. 1994;30:139-143.
287. Kurup V, Kelly K, Turjanmaa K, Alenius H, Reunala T, Palosuo T, et al. Immunoglobulin E reactivity to latex antigens in the sera of patients from Finland and the United States. J Allergy Clin Immunol 1993;91:1128-34.
288. Arellano R, Bradley J, Sussman G. Prevalence of latex sensitization among hospital physicians occupationally exposed to latex gloves. Anesthesiology 1992;77:905-8.
289. Kaniwa MA, Isama K, Nakamura A, Kantoh H, Itoh M, Miyoshi K, et al. Identification of causative chemicals of allergic contact dermatitis using a combination of patch testing in patients and chemical analysis: application to cases from rubber footwear. Contact Dermatitis 1994;30:26-34.
290. Mathias CGT. Occupational dermatoses. J Am Acad Dermatol 1988;19:1107-14.
291. Davidson CL. Occupational contact dermatitis of the upper extremity [State of the Art Reviews]. Occup Med 1993;9:59-73.
292. Rosen RH, Freeman S. Prognosis of occupational contact dermatitis in New South Wales, Australia. Contact Dermatitis 1993;29:88-93.
293. Marrakchi S, Maibach HI. What is occupational contact dermatitis? An operational definition. Dermatol Clin 1994;12: 477-84.
294. Maibach HI, Gellin. Occupational and industrial dermatology. Chicago: Year Book Medical Publishers; 1982.
295. Adams RM. Occupational skin disease. Philadelphia: WB Saunders; 1990.
296. Janniger CK, Schwartz RA. Seborrheic dermatitis. Am Fam Physician 1995;52:149-55.
297. Rebora A, Rongioletti F. The red face: seborrheic dermatitis. Clin Dermatol 1993;11:243-51.
298. Webster G. Seborrheic dermatitis. Int J Dermatol 1991; 30:843-4.
299. Efalith MTG. A double-blind, placebo-controlled, multicenter trial of lithium succinate ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol 1992;26:452-7.
300. Peter R, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrheic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol 1995;132:441-5.
301. Sams WM, Lynch PJ. Principles and practice of dermatology. New York: Churchill Livingstone; 1990. p. 381-8, 403-16.
302. Soter NA. Nummular eczematous dermatitis. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, editors. Dermatology in general medicine. New York: McGraw-Hill; 1993. p. 1564-79.
303. Berg RW, Milligan MC, Sarbaugh FC. Association of skin wetness and pH with diaper dermatitis. Pediatr Dermatol 1994;11:18-20.
304. Longhi F, Carlucci G, Bellucci R, Di Girolamo R, Palumbo G, Amerio P. Diaper dermatitis: a study of contributing factors. Contact Dermatitis 1992;26:248-52.
305. Rasmussen JE. Classification of diaper dermatitis: an overview. Pediatrician 1987;14:6-10.
306. Wolf R, Brenner S, Krakowski A. Intertriginous drug eruption. Acta Derm Venereol 1992;72:441-2.
307. Wolf R, Elman M, Brenner S. Drug-induced intertrigo. Int J Dermatol 1993;7:515-6.
308. Coldiron BM, Manders SM. Persistent Candida intertrigo treated with fluconazole. Arch Dermatol 1991;127:165-6.
309. Guitart J, Woodley DT. Intertrigo: a practical approach. Compr Ther 1994;20:402-9.
310. Botella-Estrada R, Sanmartin O, Oliver V, Febrer I, Aliaga A. Erythroderma: a clinicopathological study of 56 cases. Arch Dermatol 1994;130:1503-7.
311. Wilson DC, Jester JD, King JLE. Erythroderma and exfoliative dermatitis. Clin Dermatol 1993;11:67-72.
312. McKenna KE. Hand and foot dermatitis. In: Arndt K, LeBoit PE, Robinson JK, Wintroub BU, editors. Cutaneous medicine and surgery: an integrated program in dermatology. Vol. 188-193, 205-217. Philadelphia: W.B. Saunders; 1996.
313. Lodi A, Betti R, Chiarelli G, et al. Epidemiological, clinical and allergological observations on pompholyx. Contact Dermatitis 1992;26:17-21.
314. Rystedt I. Hand eczema in patients with history of atopic manifestations in childhood. Acta Derm Venereol 1985; 65:305-12.
315. Veien NK. Systematically induced eczema in adults. Acta Derm Venereol Suppl (Stockh) 1989;147:1-58.
316. Burrows D, Creswell S, Merrett JD. Nickel, hands and hip prostheses. Br J Dermatol 1981;105:437-44.
317. Phillips TJ, Dover JS. Leg ulcers. J Am Acad Dermatol 1991;25:965-87.
318. Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol 1993;28:623-7.
319. Bernhard JD. Lichen simplex chronicus, prurigo nodularis, and notalgia paresthetica. In: Arndt K, LeBoit PE, Robinson JK, Wintroub BU, editors. Cutaneous medicine and surgery: an integrated program in dermatology. Philadelphia: W.B. Saunders, 1996. p. 205-17.
320. Kantor GR. Evaluation of the patient with generalized pruritus. In: Bernhard JD, editor. Itch: mechanisms and management of pruritus. New York: McGraw-Hill; 1994. p. 337-46.
321. Dean EA, Bernhard JD. Recurrence of lichen simplex chronicus after surgical excision. Cutis 1987;40:157-8.
322. Bernstein JE. Capsaicin and substance P. Clin Dermatol 1992;9:497-503.
323. Tupker RA, Coenraads PJ, van der Meer JB. Treatment of prurigo nodularis, chronic prurigo and neurodermatitis circumscripta with topical capsaicin. Acta Derm Venereol 1992;72:463-5.
324. Hann SK, Cno MY, Park YK. UV treatment of generalized prurigo nodularis. Int J Dermatol 1990;29:436-7.